ctrl K

Marinus Pharmaceuticals I... (MRNS)

NASDAQ: MRNS · Real-Time Price · USD

0.55

0.00 (0.00%)

At close: Feb 10, 2025, 3:59 PM

Marinus Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	30.99M	25.48M	15.35M	1.72M	n/a	n/a	n/a	n/a
Cost of Revenue	1.93M	340K	1.48M	50.51M	503K	127K	126K	23K
Gross Profit	29.05M	25.14M	13.87M	-48.79M	-503K	-127K	-126K	-23K
Operating Income	-131.49M	-112.79M	-96.93M	-67.94M	-54.42M	-37.18M	-19.04M	-28.24M
Interest Income	8.11M	2.35M	80K	499K	354K	454K	324K	128K
Pretax Income	-142.94M	-16.43M	-98.78M	-67.47M	-54.12M	-36.73M	-18.9M	-28.64M
Net Income	-141.41M	-19.82M	-101.66M	-66.64M	-53.77M	-36.73M	-18.9M	-28.64M
Selling & General & Admin	61.15M	56.84M	37.28M	18.55M	11.46M	8.79M	6.67M	6.24M
Research & Development	99.39M	79.91M	73.52M	51.11M	42.97M	28.39M	12.38M	22M
Other Expenses	n/a	1.17M	657K	-37K	-53K	-1K	-20K	-65K
Operating Expenses	160.54M	137.93M	110.8M	69.66M	54.42M	37.18M	19.04M	28.24M
Interest Expense	16.89M	10.67M	2.58M	n/a	n/a	n/a	159K	464K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	162.47M	138.27M	112.28M	69.66M	54.42M	37.18M	19.04M	28.24M
Income Tax Expense	-1.54M	3.39M	2.88M	-833K	-354K	453K	13K	399K
Shares Outstanding (Basic)	53.75M	39.07M	36.7M	27.27M	13.63M	10.22M	5.89M	4.87M
Shares Outstanding (Diluted)	53.75M	39.07M	36.7M	27.27M	13.63M	10.22M	5.89M	4.87M
EPS (Basic)	-2.63	-0.51	-2.77	-2.44	-3.95	-3.59	-3.21	-5.88
EPS (Diluted)	-2.63	-0.51	-2.77	-2.44	-3.95	-3.59	-3.21	-5.88
EBITDA	-125.5M	-5.09M	-95.53M	-66.88M	-54.42M	-36.6M	-18.61M	-28.16M
EBIT	-126.05M	-5.75M	-96.19M	-67.47M	-54.42M	-36.73M	-18.74M	-28.18M
Depreciation & Amortization	551K	669K	667K	598K	503K	127K	126K	23K